What is HRTX's dilution risk score?

HRTX has a latest available DilutionScore record of 62/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for HRTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for HRTX?

DilutionWatch tracks 25 SEC filing types for HRTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect HRTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For HRTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for HRTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for HRTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

HRTX Dilution Risk Score: 62/100 (HIGH)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

85

📊 Float Risk

42

⚠️ Warrant Exposure

15

🔄 Convertible Debt

60

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 54%

🔄 Reverse Split model est. 70%

• 50-day avg $0.95 below $1 exchange minimum

• Only 6 months cash — financial pressure

🔁 Convertible Conversion model 40%

• Significant convertible debt: 21% potential dilution

• Elevated convertible risk (60/100)

💰 Capital Raise model 35%

• Low cash runway: 6 months remaining

🔔 Track HRTX — Get forecast alerts →

Market Data

Market Cap$164.69M

Shares Outstanding189.85M

Float135.48M

Cash$20.72M

Debt$141.63M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)

169 institutional holders · 174.51M shares

#1 Rubric Capital Management LP 30.05M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 15.62M shares

#3 Clearline Capital LP 12.24M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest43.24M

Days to Cover24.4

% of Float31.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2023-12-31

4 INSIDER TRANSACTION 2026-04-06

4 INSIDER TRANSACTION 2026-02-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual HRTX Dilution Snapshot

Heron Therapeutics, Inc. (HRTX) has a DilutionScore of 62/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 220,164.
Recent SEC activity tracked for HRTX: xbrl on 2026-06-30; 4 on 2026-04-06; 4 on 2026-02-03.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.